U.S. Central Venous Catheter Market is Estimated to Witness High Growth Owing to Opportunity for Minimally Invasive Surgeries
Central venous catheters are medical devices that are inserted through the skin into a large vein in the neck, chest, or groin to administer medications or fluids, obtain blood samples, and measure central venous pressure. The central venous catheter market has gained increased demand in recent years as these catheters can be used for intravenous access long-term, are minimally invasive, and are commonly preferred for emergency care situations.
The global U.S. Central Venous Catheter Market is estimated to be valued at US$ 1.2 billion in 2024 and is expected to exhibit a CAGR of 19% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity
Minimally invasive surgeries offer several advantages over traditional open surgeries such as less pain, fewer complications, lower costs, and shorter hospital stays. Central venous catheters are commonly used in minimally invasive surgical procedures as they can be easily inserted using image guidance for central vascular access to deliver drugs or fluids. The growing preference for minimally invasive techniques in the U.S. provides high market potential for central venous catheters usage during such surgeries.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate as high capital investments and regulatory protocols pose barriers for new entrants in the U.S. central venous catheter market. However, new technologies from startup companies can threaten existing players.
Bargaining power of buyers: The bargaining power of buyers is moderate to high as central venous catheters are integral to many healthcare procedures. Large group purchasing organizations can negotiate on price and influence market trends.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as raw materials for central venous catheters are standardized. However, stringent quality requirements give some power to key suppliers.
Threat of new substitutes: The threat of new substitutes is low as central venous catheters are highly specialized medical devices with few viable substitutes for their intended uses in medical procedures.
Competitive rivalry: The competitive rivalry in the U.S. central venous catheter market is high owing to the presence of several global and regional players offering similar product portfolios. Players compete based on product differentiation, cost, innovation, and customer relationships.
SWOT Analysis
Strengths: Growing prevalence of chronic diseases necessitating central line placement procedures and standardization of key product features provide opportunities.
Weaknesses: High costs associated for device development and manufacturing. Consolidation in healthcare can impact pricing.
Opportunities: Rising healthcare expenditures boost market prospects. Untapped growth potential in home healthcare segment.
Threats: Stringent regulatory processes increase compliance costs. Reimbursement uncertainties remain key market restraints. Product recalls affect company revenues and brand image.
Key Takeaways
The U.S. central venous catheter market is expected to witness high growth owing to rising geriatric population and chronic illnesses like cancer. U.S. Central Venous Catheter Market Size for 2024 is estimated at US$ 1 billion and is forecast to reach over US$ 2.5 billion by 2031, registering a CAGR of 19%.
Regional analysis - The Western region currently dominates U.S. central venous catheter sales owing to high disease prevalence and healthcare spending. States like California and Texas offer sizable market potential. The Southern region is poised to witness fastest gains through 2031 led by population growth in Florida, Georgia and South Carolina.
Key players - Key players operating in the U.S. central venous catheter market are C. R. Bard Inc., Teleflex Incorporated, Edwards Lifesciences Corporation, B. Braun Melsungen AG, and Baxter International Inc. These companies focus on continuous innovation through R&D investments to provide safer and more effective catheterization solutions.
Get More Insights on this Topic- https://www.marketwebjournal.com/central-venous-catheter-market-growth-analysis-and-trends/